Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors. ccm. 2023;7(2):141-144. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16403